Aranyak Rawal is a Cardiology physician affiliated with University of Colorado Health. OpenAlex indexes 26 publications with 213 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202512 payments
- Edwards Lifesciences CorporationProgram year20251 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
80.2%Beta blocker26.1%Metoprolol Succinate53%Carvedilol31%Metoprolol Tartrate16%Part D≥36 patientsStatin10.8%Atorvastatin Calcium100%Part D≥29 patients+ 8 more classes in this area
Blood & clotting
12.7%Factor Xa inhibitor7.9%Eliquis100%Part D≥16 patientsP2Y12 inhibitor2.5%Clopidogrel100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
7.2%SGLT2 inhibitor4.2%Jardiance100%Part D≥11 patientsPotassium supplement3%Potassium Chloride100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prevalence of lymphedema among Anderson-Fabry disease patients: A report from the Fabry registry
Molecular Genetics and Metabolism
2023 - PULSE TRAINS: THE RARE ECG FINDINGS IN DILATED CARDIOMYOPATHIES
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Jessica Devin, MD
University of Colorado Health
Ken Winston, MD
University of Colorado Health
Andreas Brieke, MD
University of Colorado Health
Breelyn Wilky, MD
University of Colorado Health
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Martin Leon, MD
Columbia University Irving Medical Center
Scott Solomon, MD
Brigham and Women's Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”